Over the last century, Europe – including  Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development.  However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading ->
The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading ->
Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB).  The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading ->
Leading global health experts and activists have expressed frustration and disappointment at the draft political declarations on pandemics, universal health coverage (UHC) and tuberculosis that world leaders are expected to adopt at the United Nations General Assembly (UNGA) next week. Key criticisms of the three declarations are that they offer no advancement on previous international […] Continue reading ->
High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading ->